Neurology

The CGTLive Neurology specialty topic page houses video interviews with key opinion leaders in the field of neurology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for neurologic disorders and diseases. It also contains up-to-date clinical news coverage in the field of gene and cell therapy for central nervous system disorders.

Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – November 22, 2024

November 22nd 2024

Review top news and interview highlights from the week ending November 22, 2024.

Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center
Evaluating Allogeneic CAR-T P-BCMA-ALLO1 in R/R Multiple Myeloma

November 21st 2024

Around the Helix: Cell and Gene Therapy Company Updates – November 20, 2024
Around the Helix: Cell and Gene Therapy Company Updates – November 20, 2024

November 20th 2024

Sophie Olivier, MD, the chief medical officer of Atamyo
Atamyo Therapeutics' Gene Therapy ATA-200 Cleared for US Trial in LGMD Type 2C/R5

November 19th 2024

Rachel McMinn, PhD, the founder and chief executive officer of Neurogene
Patient Treated With Neurogene’s Investigational Rett Syndrome Gene Therapy NGN-401 in Critical Condition After Developing Life-Threatening Immune Response

November 18th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.